全球重建網片市場 - 市場規模（依細分市場劃分）、佔有率、監管、報銷、手術量及預測（至 2036 年）

本報告對全球重建網片市場進行了考察和分析，提供了區域市場規模、關鍵趨勢、創新產品和技術以及競爭格局等資訊。

市場模型的主要組成如下：

已上市的重建網片及不斷變化的競爭格局

• 主要行業趨勢探討
• 重建網片市場各細分市場的年度收入及市場預測（2015-2036 年）
• 各細分市場的總手術量、數量、平均售價和市場價值的詳細數據

全球、區域與國家層面各市場的探討

• 依地區劃分的定性市場資訊針對全球趨勢的國別市場分析
• 重建網片市場的SWOT分析
• 重建網片市場競爭格局與趨勢探討

全面的視角，包括對醫療保健系統的概述，有助於深入了解市場。此外，市場參與細分提供了有關報銷政策和監管環境的信息，從而可以更深入地了解市場動態。

• 各國醫療保健系統概述
• 報銷政策
• 醫療科技監管環境

對象企業

• Allergan Aesthetics
• W. L. Gore & Associates Inc
• MTF Biologics
• Surgalign Holdings Inc
• Coloplast A/S
• Ethicon Inc
• Boston Scientific Corp
• CR Bard Inc
• Integra LifeSciences Holdings Corp
• pfm medical gmbh
• Baxter International Inc
• LifeNet Health Inc
• 其他

Reconstruction Meshes Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.

Reconstruction Meshes are surgically implantable woven sheets that are used to repair or support organs and other tissues. The meshes are made either from synthetic material and/or bioengineered from animal tissues. Reconstruction Meshes are generally available in multiple sizes, thicknesses, and pore sizes, however for this market model the meshes are segmented based on the materials used to make them.

The market for breast reconstruction is mainly driven by patients with breast cancer, as that is the most common type of cancer in women. Many breast cancer patients undergo single or double mastectomies, thus requiring breast reconstruction. This population is expected to grow as the global female population ages and the prevalence of mastectomies increases. Breast reconstruction improves the quality of life of patients, such that the number of reconstruction Interventions is expected to increase.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Reconstruction Meshes and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Reconstruction Meshes market revenue by segment and market outlooks from 2015-2036.
• Granular data on total Interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Reconstruction Meshes market.
• Competitive dynamics insights and trends provided Reconstruction Meshes market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Allergan Aesthetics, W. L. Gore & Associates Inc, MTF Biologics, Surgalign Holdings Inc, Coloplast A/S, Ethicon Inc, Boston Scientific Corp, CR Bard Inc, Integra LifeSciences Holdings Corp, pfm medical gmbh, Baxter International Inc, LifeNet Health Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Reconstruction Meshes market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Reconstruction Meshes.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Reconstruction Meshes market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Reconstruction Meshes market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.